Fib

Fibrinogen

Coagulation

What is Fibrinogen?

Fibrinogen (Factor I) is a large soluble glycoprotein produced by the liver that is essential for blood clot formation. It is the precursor to fibrin, the protein that forms the structural mesh of blood clots. When the coagulation cascade is activated (through either the intrinsic or extrinsic pathway), thrombin cleaves fibrinogen into fibrin monomers, which polymerize and are cross-linked by Factor XIII to form a stable clot. Fibrinogen also plays a crucial role in platelet aggregation, acting as a bridge between activated platelets via glycoprotein IIb/IIIa receptors.

Beyond its hemostatic role, fibrinogen is a major acute-phase protein—its concentration increases significantly during inflammation, infection, tissue injury, and malignancy. This dual role as both a clotting factor and an inflammatory marker makes fibrinogen clinically relevant across multiple medical specialties. Fibrinogen measurement is essential in evaluating bleeding disorders, monitoring disseminated intravascular coagulation (DIC), guiding transfusion in massive hemorrhage, and assessing cardiovascular risk. It has a half-life of approximately 3–5 days and is measured by functional (Clauss method) or immunologic assays.

Why It Matters

Fibrinogen is essential for normal blood clotting—without it, even minor injuries can lead to uncontrolled bleeding. Low fibrinogen is a critical finding in DIC, massive hemorrhage, and liver failure that requires urgent replacement. Elevated fibrinogen is both an acute-phase marker of inflammation and an independent risk factor for cardiovascular events, stroke, and venous thromboembolism. Monitoring fibrinogen is crucial in trauma, surgery, obstetric emergencies, and the management of DIC, where its rapid decline signals consumption of clotting factors.

Normal Reference Ranges

GroupRangeUnit
Adults200–400mg/dL
Newborns125–300mg/dL
Critical low (bleeding risk)<100mg/dL
Pregnancy (3rd trimester)400–600mg/dL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High Fib Levels Mean

Common Causes

  • Acute infection or inflammation (acute-phase response)
  • Tissue injury, surgery, or trauma
  • Malignancy
  • Pregnancy
  • Smoking
  • Obesity
  • Oral contraceptive or estrogen use
  • Nephrotic syndrome
  • Coronary artery disease

Possible Symptoms

  • Fibrinogen elevation itself is usually asymptomatic
  • Increased blood viscosity (in very high levels)
  • Symptoms related to the underlying inflammatory condition
  • May contribute to increased clotting risk over time

What to do: Elevated fibrinogen as part of an acute-phase response is typically transient and resolves with treatment of the underlying condition. Check CRP and ESR to assess the degree of inflammation. Chronically elevated fibrinogen is associated with increased cardiovascular risk—address modifiable risk factors including smoking cessation, weight management, exercise, and treatment of underlying inflammatory conditions. There are no medications specifically aimed at lowering fibrinogen, though fibrates and fish oil may have modest effects. If markedly elevated (>700 mg/dL), consider an underlying malignancy workup.

What Low Fib Levels Mean

Common Causes

  • Disseminated intravascular coagulation (DIC)
  • Massive hemorrhage with consumption
  • Severe liver disease (decreased production)
  • Congenital afibrinogenemia or hypofibrinogenemia
  • Thrombolytic therapy (tPA, streptokinase)
  • Severe malnutrition
  • Snake envenomation (certain species)
  • L-asparaginase therapy

Possible Symptoms

  • Easy bruising
  • Prolonged bleeding from cuts or wounds
  • Nosebleeds (epistaxis)
  • Heavy menstrual bleeding
  • Bleeding from gums
  • Post-surgical or post-traumatic hemorrhage
  • Joint or muscle bleeding (in severe deficiency)

What to do: Fibrinogen <100 mg/dL with active bleeding requires immediate replacement with cryoprecipitate (each unit raises fibrinogen by approximately 5–10 mg/dL) or fibrinogen concentrate. In DIC, treat the underlying cause (sepsis, obstetric complications, malignancy) while supporting with transfusion of blood products. Check PT, aPTT, D-dimer, platelet count, and blood smear to assess for DIC. In liver disease, fibrinogen falls when synthetic capacity is severely impaired—this is a marker of advanced disease. Congenital fibrinogen disorders require hematology management with prophylactic replacement for procedures.

When Is Fib Testing Recommended?

  • When evaluating DIC in critically ill patients
  • During massive hemorrhage or trauma resuscitation
  • When assessing unexplained bleeding or bruising
  • Before and after thrombolytic therapy
  • As part of cardiovascular risk assessment
  • When liver synthetic function is in question

Frequently Asked Questions

Disseminated intravascular coagulation (DIC) is a condition where the coagulation system is pathologically activated throughout the body, consuming clotting factors and platelets while simultaneously generating microthrombi and secondary fibrinolysis. Fibrinogen is one of the key factors consumed in DIC, and its declining level is both diagnostic and prognostic. The International Society on Thrombosis and Haemostasis (ISTH) DIC score includes fibrinogen along with platelet count, D-dimer, and PT. A rapidly falling fibrinogen in the context of sepsis, trauma, obstetric complications, or malignancy is a red flag for DIC. However, because fibrinogen is an acute-phase reactant, it may remain in the normal range early in DIC even as other factors are being consumed—so serial measurements are more informative than a single value.
Yes. Multiple large prospective studies (including the Framingham Heart Study and the EUROSTROKE project) have demonstrated that elevated fibrinogen is an independent risk factor for coronary heart disease, stroke, and peripheral arterial disease. The Fibrinogen Studies Collaboration, a meta-analysis of 154,211 participants, found that each 1 g/L increase in fibrinogen was associated with approximately twice the risk of coronary heart disease, stroke, and vascular mortality. Fibrinogen promotes atherosclerosis through multiple mechanisms: it increases blood viscosity, enhances platelet aggregation, promotes fibrin deposition in vessel walls, and binds inflammatory cells. However, unlike cholesterol, there is no specific pharmacotherapy to lower fibrinogen, so management focuses on treating the associated risk factors.
Fibrinogen increases significantly during pregnancy, reaching levels of 400–600 mg/dL (or higher) by the third trimester—roughly 50% above non-pregnant levels. This physiologic adaptation prepares the body for hemostasis during delivery, where rapid clot formation at the placental site is essential to prevent postpartum hemorrhage. The placental bed receives approximately 600 mL/min of blood flow at term, and effective hemostasis after placental separation depends heavily on both uterine contraction and coagulation. This hypercoagulable state, while protective against bleeding, also contributes to the increased risk of venous thromboembolism during pregnancy and the postpartum period. In obstetric emergencies like placental abruption or amniotic fluid embolism, rapid consumption of fibrinogen can lead to DIC, making fibrinogen monitoring critical.

Related Biomarkers

D-DD-DimerPT/INRProthrombin Time

Want your Fib levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.